(Press-News.org) ORLANDO, Fla., August 13, 2012 – To survive, tumors need blood supply to provide them with nutrients and oxygen. To get that supply, cancer cells stimulate new blood vessel growth—a process called tumor angiogenesis. Many attempts have been made to inhibit this process as a means to choke off tumors. But tumor angiogenesis can be sloppy, resulting in immature and malformed blood vessels. Since anti-cancer drugs are carried to tumors by the bloodstream, abnormal blood vessel development also hampers delivery. What if, rather than putting a stop to angiogenesis, we could help tumor blood vessels mature more completely, so tumor-killing therapies could more effectively reach their targets? This counterintuitive concept was proposed several years ago, but researchers lacked a way to do it. Now, in a paper published August 14 in the journal Cancer Cell, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) found a molecule that promotes the tumor vessel maturation process—a discovery that might provide a method for improving cancer drug delivery.
"Our finding suggests that an ability to regulate this molecule could allow us to solve various problems caused by blood vessel abnormalities, including inefficient drug delivery to tumors," said Masanobu Komatsu, Ph.D., associate professor at Sanford-Burnham and senior author of the study.
Tumor vessels: shut them down or repair them?
Previous cancer therapies aimed at tumor angiogenesis were developed with a simple hypothesis: kill the blood vessels that feed a tumor, and tumor cells starve and die. While drugs engineered to slow or halt angiogenesis have been somewhat successful, tumor cells are notoriously adept at surviving in the nutrient and oxygen-deprived environment. So, anti-angiogenic drugs are one possible weapon in medicine's arsenal against tumors, but others are needed.
Komatsu's strategy is based on a new understanding of one particular protein, called R-Ras. He and his team found that R-Ras helps blood vessels mature. The protein is found at high levels in normal, mature blood vessels. Tumor blood vessels, on the other hand, usually have very low R-Ras levels, accounting for their immature nature.
To examine the importance of R-Ras in tumor vessel maturation, Komatsu and his team tried boosting the protein in mice.
"Tumor vessels are chronically immature because they lack R-Ras," said Komatsu. "We found that if we introduce R-Ras there, we are able to normalize the blood vessel in the tumor environment—improving vessel structure and function."
Harnessing angiogenesis to improve human health
Rather than worrying that improved vessel function might help a tumor blossom, Komatsu sees it another way—using R-Ras to help tumor blood vessels mature might better enable the delivery of therapeutic drugs straight to the tumor.
Increasing R-Ras activity could also have other benefits. These include any situation where functionally mature blood vessels are needed, such as in tissue engineering when transplanted tissues need an ample blood supply. Elevating R-Ras could also be important in heart attack patients, where functional and stable new vessels are needed to re-nourish heart muscle. In brain cancer, R-Ras could help patients suffering from swelling in the brain in the area surrounding the tumor—a life-threatening situation caused by leaky blood vessels.
"Our discovery provided a better understanding of blood vessel formation process and may prompt researchers to re-think how this process may be controlled to improve human health," Komatsu said.
INFORMATION:
This research was funded by the National Cancer Institute at the U.S. National Institutes of Health (grant numbers CA125255, CA030199, and CA104898), American Cancer Society, Bankhead-Coley Cancer Research Program, Florida Breast Cancer Foundation Fellowship Award, and funds provided by the Department of Pathology, University of Alabama at Birmingham and Sanford-Burnham.
The study was co-authored by: Junko Sawada, Sanford-Burnham; Takeo Urakami, Sanford-Burnham; Fangfei Li, Sanford-Burnham; Akane Urakami, Sanford-Burnham, Weiquan Zhu, University of Utah; Minoru Fukuda, Sanford-Burnham; Dean Y. Li, University of Utah; Erkki Ruoslahti, Sanford-Burnham and University of California, Santa Barbara; and Masanobu Komatsu, Sanford-Burnham.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, non-profit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, news, and events, please visit us at sanfordburnham.org.
Protein that helps tumor blood vessels mature could make cancer drugs more effective
Sanford-Burnham researchers discover molecule that controls tumor vessel maturation -- a counterintuitive approach that could improve cancer drug delivery
2012-08-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Journal of Clinical Investigation early table of contents for Aug. 13, 2012
2012-08-13
New class of proteins allows breast cancer cells to evade Tyrosine Kinase Inhibitors
Aberrant regulation of cell growth pathways is required for normal cells to become cancerous, and in many types of cancer, cell growth is driven by a group of enzymes known as receptor tyrosine kinases (RTKs). The RTK epidermal growth factor receptor (EGFR) is overexpressed in over 30% of breast cancers; however, drugs that target RTKs, known as tyrosine kinase inhibitors (TKIs) have not been effective in treating breast cancer. Researchers believe that the cancer cells escape TKIs by ...
CNIO researchers discover a new therapy that prevents lung cancer growth in mice
2012-08-13
Lung cancer is one of the most aggressive types of cancer and the most common cause of death from this disease worldwide. Despite the progress in the molecular biology of lung cancer achieved in recent years, the mechanisms used by tumor cells to grow and spread throughout the body are not yet completely understood. This lack of information is responsible for the limited range of available therapeutic possibilities and their undesirable side effects.
The Tumour Suppression Group of the Spanish National Cancer Research Centre (CNIO), led by Manuel Serrano, has deciphered ...
Fruity science halves fat in chocolate
2012-08-13
Scientists have found a way to replace up to 50 per cent of chocolate's fat content with fruit juice.
University of Warwick chemists have taken out much of the cocoa butter and milk fats that go into chocolate bars, substituting them with tiny droplets of juice measuring under 30 microns in diameter.
They infused orange and cranberry juice into milk, dark and white chocolate using what is known as a Pickering emulsion.
Crucially, the clever chemistry does not take away the chocolatey 'mouth-feel' given by the fatty ingredients.
This is because the new technique maintains ...
New bacteria-resistant materials discovered
2012-08-13
Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.
Medical device associated infections can lead to systemic infections or device failure, costing the NHS £1bn a year. Affecting many commonly used devices including urinary and venous catheters — bacteria form communities known as biofilms. This 'strength in numbers approach' protects them against the bodies' ...
The ins and outs of building the sperm tail
2012-08-13
Sperm swim, lung cells sweep mucus away, and the cells in the female Fallopian tube move eggs from the ovary to the uterus. Underlying these phenomena are flagella – slender, hair-like structures extending from the surface of the cells, that bend, beat or wave rhythmically. In the latest issue of the journal Developmental Cell*, scientists from the Instituto Gulbenkian de Ciência (IGC), in Portugal, have dissected how sperm cells of the fruit fly build their flagella. These findings pave the way to further understand the molecules and processes that may trigger a variety ...
NTU scientist invents pocket living room TV
2012-08-13
Leaving your TV show midway because you had to leave your home will no longer happen as you can now 'pull' the programme on your TV screen onto your tablet and continue watching it seamlessly.
You can also watch the same TV show or movie together with your family and friends, no matter which part of the world they are in. Not only that but you'll be able to discuss the show, whether you are on your personal tablet or smart phone, through a channel of your choice, be it video chat, voice or text.
The world's first 'pick up and throw back' video feature allows your video ...
Smoking increases, while alcohol consumption may decrease risk of ALS
2012-08-13
A population-based case-control study of the rare but devastating neurological disease amyotrophic lateral sclerosis (ALS) has shown that the risk of such disease is increased among smokers, as has been shown previously. However, surprisingly, the risk of ALS was found to be markedly lower among consumers of alcohol than among abstainers.
Forum reviewers thought that this was a well-done and important paper, as it is a population-based analysis, with almost 500 cases of ALS, a very large number of cases for this rare disease. They were especially struck by the magnitude ...
Clemson researchers make optical fibers from common materials
2012-08-13
CLEMSON — Clemson researchers are taking common materials to uncommon places by transforming easily obtainable and affordable materials into fiber. Their findings are published in Nature Photonics, the world's top journal focused on light-based technologies.
"We have used a highly purified version of beach sand (silica) for fiber for the last 40 years," said John Ballato, director of the Center for Optical Materials Science and Engineering Technologies at Clemson University. "As a matter of fact, the 2009 Nobel Prize in Physics was awarded for the development of silica ...
BUSM researchers part of multi-center study on cardiac amyloidosis
2012-08-13
(Boston) - Researchers at Boston University School of Medicine (BUSM) have been part of a multicenter observational study called TRACS (Transthyretin Amyloidosis Cardiac Study) to help determine the health significance of a particular gene mutation which is commonly found in Black Americans.
The gene, transthyretin (TTR) and the mutation V122I, is seen in about four percent of African Americans or roughly 1.5 million people. The mutation is strongly associated with a condition called cardiac amyloidosis - a disorder where the abnormally mutated TTR protein deposits in ...
The NBA league is more equal than the ACB
2012-08-13
Competitiveness amongst NBA teams is more constant throughout seasons than during the ACB basketball league (Spain), which also falls after every Olympic Games. According to a study from the University of Las Palmas de Gran Canaria, the differences could be attributed to economic and organisational reasons: in the NBA there is just one division, there is a salary cap and the weakest teams have access to good players.
The National Basketball Association (NBA) of North America and the Association of Basketball Clubs (ACB) of Spain are the best and most competitive basketball ...
LAST 30 PRESS RELEASES:
20% of butterflies in the U.S. have disappeared since 2000
Bacterial ‘jumping genes’ can target and control chromosome ends
Scientists identify genes that make humans and Labradors more likely to become obese
Early-life gut microbes may protect against diabetes, research in mice suggests
Study raises the possibility of a country without butterflies
Study reveals obesity gene in dogs that is relevant to human obesity studies
A rapid decline in US butterfly populations
Indigenous farming practices have shaped manioc’s genetic diversity for millennia
Controlling electrons in molecules at ultrafast timescales
Tropical forests in the Americas are struggling to keep pace with climate change
Brain mapping unlocks key Alzheimer’s insights
Clinical trial tests novel stem-cell treatment for Parkinson’s disease
Awareness of rocky mountain spotted fever saves lives
Breakthrough in noninvasive monitoring of molecular processes in deep tissue
BU researcher named rising star in endocrinology
Stressed New Yorkers can now seek care at Mount Sinai’s new resilience-focused medical practice
BU researchers uncover links between metabolism and aggressive breast cancer
Engineers took apart batteries from Tesla and China’s leading EV manufacturer to see what’s inside
Paralyzed man moves robotic arm with his thoughts
Planetary science: More potential locations for ice on Moon
Injectable Therapy is 'magic' for those who can’t take HIV pills
siRNA-AGO2 complex inhibits bacterial gene translation: a novel therapeutic strategy for superbug infection
Memory is impaired in aged rats after 3 days of high-fat eating
Artificial muscles for tremor suppression
A new way to engineer composite materials
AERA selects 29 exemplary scholars as 2025 Fellows
Touchless tech: Control fabrics with a wave of your finger
JMIR aging invites submissions on the social and cultural drivers of health in aging adults
New research sheds light on why scleroderma affects mostly women and how to treat it
Lack of appropriate mental health care impacts quality of life for people with COPD
[Press-News.org] Protein that helps tumor blood vessels mature could make cancer drugs more effectiveSanford-Burnham researchers discover molecule that controls tumor vessel maturation -- a counterintuitive approach that could improve cancer drug delivery